The Effect of Antiretroviral Therapy (ART) Duration on CD4 Counts in Human Immunodeficiency Virus (HIV) Patients in dr. Doris Sylvanus Regional Hospital


  • Oberson Nainggolan Faculty of Medicine Universitas Palangka Raya Palangka Raya
  • Lia Sasmithae Department of Internal Medicine Faculty of Medicine Universitas Palangka Raya Palangka Raya
  • Ratna Widayati Department of Biochemistry and Molecular Biology Faculty of Medicine Universitas Palangka Raya Palangka Raya



Cluster of differentiation 4, HIV, therapy duration


Human Immunodeficiency Virus (HIV) attacks white blood cells, thereby reducing the immunity of infected patients. It attacks Cluster of Differentiation 4 (CD4) lymphocyte cells which have a role in the immune system. It has killed 36.3 million people worldwide. There were reported 222 cases in Central Kalimantan Province in 2019. The therapy given to suppress HIV is antiretroviral (ARV) which gradually recover CD4 cells of the patients. This study aims to determine the effect of duration of the antiretroviral therapy (ART) duration on CD4 counts in patients with HIV at the VCT (Voluntary, Counselling, and Test) Polyclinic, dr. Doris Sylvanus Hospital during 2019-2020. It is a descriptive retrospective study, extracting data from patients medical record data. Following total sampling and selected based on inclusion and exclusion criteria i.e. aged ≥18 years and diagnosed with HIV during 2019-2020, with complete CD4 count records prior and after ART, there were 45 patients included. The results showed that CD4 counts increased in patients with fixed dose combination (FDC) Tenofovir, lamivudine and efavirenz, with average value of 190.36± 220.92 cells/mm3 prior ART, became 259.93± 203.74 cells/mm3 at 12 month ART, and 310.82± 22.,53 cells/mm3 at 24 month ART (p = 0.000). Thus, the longer ART duration the higher CD4 counts and recover the normal range.


Download data is not yet available.


World Health Organization. HIV/AIDS. (Online) 2021. [accessed 2022 March 29]

Pusat data dan informasi. Situasi Umum HIV, AIDS, Dan Tes HIV. (Online) 2019. [accessed 2022 Mar 29].

Malhotra P, Haslett P, Sherry B, et al. Increased Plasma Levels of The TH2 Chemokine CCL18 Associated with Low CD4+ T Cell Counts in HIV-1-Infected Patients with a Suppressed Viral Load. Scientific Reports. 2019; 9(1): 1-8

Kementrian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/90/2019 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana HIV. Jakarta: Kemenkes RI; 2019: p. 8–20.

Adiningsih S, Widiyanti M, Natalia EI, and Wahyuni T. CD4+ dan Faktor yang Memengaruhi Kepatuhan Terapi Antiretroviral pada Orang dengan HIV/AIDS di Jayapura. Buletin Penelitian Kesehatan. 2018; 46(2): 87–96.

Mutoh Y, Nishijima T, Inaba Y, et al. Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients with Human Immunodeficiency Virus Infection and Suppressed Viremia during Long-Term Antiretroviral Therapy. Clinical Infectious Diseases. 2018; 67(6): 927–933.

Akullian A, Vandormael A, Miller JC, et al. Large Age Shifts in HIV-1 Incidence Patterns in KwaZulu-Natal, South Africa. Proceedings of the National Academy of Sciences. 2021; 118(28): 1-8.

de Armas LR, Pallikkuth S, Pan L, Rinaldi S, Pahwa R, and Pahwa S. Immunological Age Prediction In HIV-Infected, ART-Treated Individuals. Aging. 2021; 13(19): 22772–22791.

Szwarcwald CL, de Souza Júnior PRB, Pascom ARP, et al. HIV Incidence Estimates by Sex and Age Group in the Population Aged 15 Years or Over, Brazil, 1986-2018. Revista da Sociedade Brasileira de Medicina Tropical. 2022; 55(1): 1-11.

Girum T, Wasie A, Lentiro K, et al. Gender Disparity in Epidemiological Trend of HIV/AIDS Infection and Treatment in Ethiopia. Archives of Public Health. 2018; 76(1): 1-10.

Marshalita N. Gambaran Karakteristik Pasien HIV/AIDS di RSUD DR. H. Abdul Moeloek Bandar Lampung Periode Oktober 2017-Oktober 2018. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia. 2018; 8(1): 9–16.

Caesaria S, Robiyanto, and Untari EK. Profil Karakteristik Pada Pasien HIV/AIDS dengan Terapi Antiretroviral di Klinik CST RSJD Sungai Bangkong Pontianak. Jurnal Mahasiswa Farmasi Fakultas Kedokteran UNTAN. 2019; 4(1): 1-7.

Manalu RM, Harahap SY, and Sinurat I. Faktor-Faktor Yang Mempengaruhi Kejadian Infeksi HIV pada Usia Produktif di Komite AIDS HKBP Balige. Indonesian Trust Health Journal. 2019; 2(2): 190–198.

Kreniske P, Grilo S, Nakyanjo N, Nalugoda F, Wolfe J, and Santelli JS. Narrating the Transition to Adulthood for Youth in Uganda: Leaving School, Mobility, Risky Occupations, and HIV. Health Education & Behavior. 2019; 46(4): 550–558.

Ladyani F and Kiristianingsih A. Hubungan antara Jumlah CD4 pada Pasien yang Terinfeksi HIV/AIDS dengan Infeksi Oportunistik di Rumah Sakit Umum Abdul Moeloek Bandar Lampung Tahun 2016. JK UNILA: Jurnal kedokteran Universitas Lampung. 2019; 3(1): 34-41.

Syafirah Y, Rahmatini R, and Bahar E. Gambaran Pemberian Regimen Antiretroviral pada Pasien HIV/AIDS Di RSUP Dr. M. Djamil Padang Tahun 2017. Jurnal Kesehatan Andalas. 2020; 9(1): 147-155.

Dereje N, Moges K, Nigatu Y, and Holland R. Prevalence and Predictors of Opportunistic Infections among HIV Positive Adults on Antiretroviral Therapy (On-ART) versus Pre-ART in Addis Ababa, Ethiopia: A Comparative Cross-Sectional Study. HIV/AIDS: Research and Palliative Care. 2019; 11: 229–237.

Hamada Y, Getahun H, Tadesse BT, and Ford N. HIV-Associated Tuberculosis. International Journal of STD & AIDS. 2021; 32(9): 780–790.

Cribbs SK, Crothers K, and Morris A. Pathogenesis of HIV-Related Lung Disease: Immunity, Infection, and Inflammation. Physiological Reviews. 2020; 100(2): 603–632.

Truong J and Ashurst JV. Pneumocystis jirovecii Pneumonia. Florida: StatPearls Publishing; 2022; p. 8–7.

Gingerich AD, Norris KA, and Mousa JJ. Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments. Pathogens. 2021; 10(2): 1-15.

Bayarsaikhan S, Jagdagsuren D, Gunchin B, and Sandag T. Survival, CD4 T Lymphocyte Count Recovery and Immune Reconstitution Pattern during the First-Line Combination Antiretroviral Therapy in Patients with HIV-1 Infection in Mongolia. PLoS One. 2021; 16(3): 1-14.

Nurmawati T, Sari YK, and Hidayat AP. Hubungan antara Lama Pengobatan dengan Jumlah CD4 pada Penderita HIV/AIDS yang Menjalankan Program Pengobatan Antiretrovial (ARV). Jurnal Ners dan Kebidanan (Journal of Ners and Midwifery). 2019; 6(2): 197–202.

Permatasari J, Meirista I, and Bafadhal H. Hubungan Kombinasi Antiretroviral Terhadap Kadar CD4 Pasien HIV TB Rawat Jalan RSUD H. Abdul Manap Jambi. Journal of Pharmacy and Science. 2021; 6(2): 75-79.






Research Article